Zylox-Tonbridge Medical Technology (HKG: 2190), a leading developer of nerve and peripheral vascular interventional devices based in China, has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its ZYLOX Penguin iliac vein stent system. This innovative product is designed for the treatment of iliac vein compression syndrome (IVCS).
The ZYLOX Penguin stent system is the result of a collaborative effort between Zylox-Tonbridge and the First Affiliated Hospital of Chongqing Medical University, showcasing an integration of medical and military technology. The product’s design includes superior adhesion and a unique gradual chronic dilation feature, which can significantly reduce the risk of thrombosis. Additionally, it accommodates the natural diameter changes of blood vessels, ensuring the safety and efficacy of the treatment.- Flcube.com
